切换至 "中华医学电子期刊资源库"

中华实验和临床感染病杂志(电子版) ›› 2016, Vol. 10 ›› Issue (06) : 659 -662. doi: 10.3877/cma.j.issn.1674-1358.2016.06.003

综述

肠黏膜屏障功能障碍在重症急性胰腺炎中的研究进展
陈辉1, 兰涛1,()   
  1. 1. 061000 沧州市,南方医科大学附属沧州市人民医院肝胆胰外科
  • 收稿日期:2015-08-28 出版日期:2016-12-15
  • 通信作者: 兰涛
  • 基金资助:
    河北省卫生厅医学研究课题(No. 1120140016)

Progress of intestinal mucosal barrier dysfunction in severe acute pancreatitis

Hui Chen1, Tao Lan1,()   

  1. 1. Department of Hepatobiliary and Pancreatic Surgery, Cangzhou People’s Hospital, Southern Medical University, Cangzhou 061000, China
  • Received:2015-08-28 Published:2016-12-15
  • Corresponding author: Tao Lan
引用本文:

陈辉, 兰涛. 肠黏膜屏障功能障碍在重症急性胰腺炎中的研究进展[J]. 中华实验和临床感染病杂志(电子版), 2016, 10(06): 659-662.

Hui Chen, Tao Lan. Progress of intestinal mucosal barrier dysfunction in severe acute pancreatitis[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2016, 10(06): 659-662.

重症急性胰腺炎(SAP)病情险恶、并发症多,且病死率高。过去几十年来,SAP发病率显著增加,SAP可导致肠道黏膜屏障损伤,从而引起细菌或内毒素易位,继而出现胰腺组织继发感染,导致全身炎症反应综合征(SIRS)及多器官功能障碍综合征,进而影响SAP患者的预后。在SAP发病过程中肠黏膜屏障损伤具有重要作用。因此,对肠道黏膜屏障功能障碍在SAP发病机制研究中尤为重要。现将重症急性胰腺炎肠黏膜屏障功能障碍的研究进展进行综述。

Severe acute pancreatitis (SAP) is a severe disease, with many complications and high fatality rate. In the past few decades, the incidence rate of SAP increased significantly, which could damage the intestinal mucosa barrier, lead to bacterial and endotoxin translocation, pancreatic tissue infection, and then systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome, eventually affects the prognosis of the patients. During SAP, intestinal mucosa barrier damage plays a key role. Therefore, the research of intestinal mucosal barrier dysfunction mechanism in SAP is important. The progress of intestinal mucosal barrier dysfunction in SAP were reviewed.

1
Werner J, Feuerbach S, Uhl W, et al. Management of acute pancreatitis: from surgery to interventional intensive care[J]. Gut,2005,54(3):426-436.
2
van Baal MC, van Santvoort HC, Bollen TL, et al. Systematic review of percutaneous catheter drainage as primary treatment for necrotizing pancreatitis[J]. Br J Surg,2011,98(1):18-27.
3
Zerem E, Imamović G, Sušić A, et al. Step-up approach to infected necrotising pancreatitis: a 20-year experience of percutaneous drainage in a single centre[J]. Dig Liver Dis,2011,43(6):478-483.
4
Rebours V. Acute pancreatitis: an overview of the management[J]. Rev Med Interne,2014,35(10):649-655.
5
曲鹏飞,苗彬,崔乃强. 重症急性胰腺炎感染与肠屏障学术进展[J]. 中国中西医结合外科杂志,2008,14(3):307-309.
6
Garside P, Millington O, Smith KM. The anatomy of mucosal immune responses[J]. Ann N Y Acad Sci,2004,1029(1):9-15.
7
Yang YJ, Gao NR. Influence of endogenous nitrogen monoxidum on permeability of intestinal mucosa of rats with acute necrotic pancreatitis[J]. World Chin J Digestol,2005,13(3):389-391.
8
张浩,崔乃强. 肠屏障与多器官功能障碍综合征[J]. 中国中西医结合外科杂志,2007,13(3):316-318.
9
Man AL, Gicheva N, Nicoletti C. The impact of ageing on the intestinal epithelial barrier and immune system[J]. Cell Immunol,2014,289(1-2):112-118.
10
Rahman SH, Ammori BJ, Holmfield J, et al. Intestinal hypoperfusion contributes to gut barrier failure in severe acute pancreatitis[J]. J Gastrointest Surg,2003,7(1):26-35.
11
Zhang JX, Qu JG, Cheng GZ, et al. Changes of intestinal blood flow and phospholipase A2, interleukin-1β in serum of rats with acute necrotic pancreatitis[J]. Basic Med Sci Clin,2003,23(5):556-558.
12
Shames BD, Barton HH, Reznikov LL, et al. Ischemia alone is sufficient to induce TNF-alpha mRNA and peptide in the myocardium[J]. Shock,2002,17(2):114-119.
13
Kianian M, Kelly ME, Zhou J, et al. Cannabinoid receptor 1 inhibition improves the intestinal microcirculation[J]. Clin Hemorheol Microcirc,2014,58(2):333-342.
14
Yang FR, Lin XZ. Study progress on intestinal ischemical reperfusion injury[J]. Chin J Integr Tradit Western Med,2002,8(4):319-321.
15
Qiu Y, Yu M, Yang Y, et al. Disturbance of intraepithelial lymphocytes in a murine model of acute intestinal ischemia/reperfusion[J]. J Mol Histol,2014,45(2):217-227.
16
Tian R, Tan JT, Wang RL, et al. The role of intestinal mucosa oxidative stress in gut barrier dysfunction of severe acute pancreatitis[J]. Eur Rev Med Pharmacol Sci,2013,17(3):349-355.
17
耿艳霞,黎介寿. 表皮生长因子对大鼠小肠缺血-再灌注损伤的保护作用[J]. 肠外与肠内营养杂志,2013,20(1):29-32.
18
Wang XP, Wang BX, Wu K, et al. Excessive cytokine expression mediated by NF-κB of intestinal mucosa and role of somatropin in acute necrotic pancreatitis[J]. Chin J Hepatobiliary Surg,2003,9(1):45-49.
19
Ji L, Yuan YZ, Xu JY. NF-κB and acute pancreatitis[J]. Forei Med Intern Med,2000,27(9):396-398.
20
Yin JB, Xiao JM, Wang YQ, et al. Acute pancreatitis and intestinal barrier injury, bacteria translocation and endotoxemia[J]. Chin J Coal Ind Med,2005,8(4):317-320.
21
Lu ZK,Ye JX, Chen WC. Vasoactive intestinal peptide promotes gut barrier function against severe acute pancreatitis[J]. Mol Biol Rep,2012,39(4):3557-3563.
22
Chen X, Zhao HX, Fu XS, et al. Glucagonlike peptide 2 protects intestinal barrier in severe acute pancreatitis through regulating intestinalepithelial cell proliferation and apoptosis[J]. Pancreas,2012,41(7):1080-1085.
23
Rao RK, Samak G2. Protection and restitution of gut barrier by probiotics: nutritional and clinical implications[J]. Curr Nutr Food Sci,2013,9(2):99-107.
24
Han T, Li XL, Cai DL, et al. Effects of glutamine-supplemented enteral or parenteral nutrition on apoptosis of intestinal mucosal cells in rats with severe acute pancreatitis[J]. Eur Rev Med Pharmacol Sci,2013,17(11):1529-1535.
25
Grady EF, Yoshimi SK, Maa J, et al. Substance P mediates inflammatory oedema in acute pancreatitis via activation of the neurokinin-1 receptor in rats and mice[J]. Br J Pharmacol,2000,130(3):505-512.
26
Zheng TB, Shi X, Gao NR, et al. Expression of NK-1R and NK-2R in colon during acute necrotic pancreatitis[J]. J Pract Med,2002,18(12):1272-1274.
27
Kagnoff MF. The intestinal epithelium is an integral component of a communications network[J]. J Clin Invest,2014,124(7):2841-2843.
28
Lutgendorff F, Nijmeijer RM, Sandström PA, et al. Probiotics prevent intestinal barrier dysfunction in acute pancreatitis in rats via induction of ileal mucosal glutathione biosynthesis[J]. PLoS One,2009,4(2):e4512.
29
Wang H, Zhang W, Zuo L, et al. Intestinal dysbacteriosis contributes to decreased intestinal mucosal barrier function and increased bacterial translocation[J]. Lett Appl Microbiol,2014,58(4):384-392.
[1] 徐娟, 孙汝贤, 赵东亚, 张清艳, 金兆辰, 蔡燕. 右美托咪定序贯镇静模式对中深度镇静的机械通气患者预后和谵妄的影响[J]. 中华危重症医学杂志(电子版), 2023, 16(05): 363-369.
[2] 张秋彬, 张楠, 林清婷, 徐军, 朱华栋, 姜辉. 急性胰腺炎合并急性肾损伤患者的预后评估[J]. 中华危重症医学杂志(电子版), 2023, 16(05): 382-389.
[3] 黄翠君, 张喜玲, 刘思嘉, 刘云建. 重症急性胰腺炎营养支持治疗研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(05): 385-390.
[4] 张海涛, 康婵娟, 翟静洁. 胰管支架置入治疗急性胆源性胰腺炎效果观察[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 654-657.
[5] 江文诗, 何湘湘. 全球及我国器官捐献发展特征分析与学科建设[J]. 中华移植杂志(电子版), 2023, 17(05): 280-286.
[6] 陈朔, 陈峰, 程飞, 项捷. 糖原累积病Ⅰ型并发胰腺炎肝移植术后胰腺梗死一例[J]. 中华移植杂志(电子版), 2023, 17(05): 300-302.
[7] 伍学成, 李远伟, 袁武雄, 王建松, 石泳中, 卢强, 李卓, 陈佳, 刘哲, 滕伊漓, 高智勇. 炎症介质谱联合降钙素原在尿源性脓毒血症中的诊断价值[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 476-480.
[8] 王小红, 钱晶, 翁文俊, 周国雄, 朱顺星, 祁小鸣, 刘春, 王萍, 沈伟, 程睿智, 秦璟灏. 巯基丙酮酸硫基转移酶调控核因子κB信号介导自噬对重症急性胰腺炎大鼠的影响及机制[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 422-426.
[9] 陆萍, 邹健. 凝血和纤维蛋白溶解标志物的动态变化对急性胰腺炎患者预后的评估价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 427-432.
[10] 吉茜茜, 田尧, 马林, 钱进. 红细胞分布宽度-白蛋白比值联合BISAP评分对急性胰腺炎严重程度及死亡率的预测价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 433-438.
[11] 黄岩, 刘晓巍, 杨春玲, 兰烨. 急性胰腺炎合并糖尿病患者的临床特征及血糖代谢与病情严重度的相关性[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 439-442.
[12] 孙旻. 血液淀粉酶、C反应蛋白、降钙素原及乳酸脱氢酶在急性胰腺炎患者病情评价及预后预测中的价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 331-336.
[13] 马强, 李军, 苟丽娟. 重症急性胰腺炎miR-21-3p、RUNX3表达水平及对病情发展程度的预测[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 337-341.
[14] 李琪, 黄钟莹, 袁平, 关振鹏. 基于某三级医院的ICU多重耐药菌医院感染影响因素的分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 777-782.
[15] 刘平娟, 罗科城, 吴家茵, 廖康, 胡雯雯, 陈怡丽. 神经内科重症监护室患者肠道耐碳青霉烯类肠杆菌目细菌主动筛查研究[J]. 中华临床实验室管理电子杂志, 2023, 11(04): 235-240.
阅读次数
全文


摘要